Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Histopathology of multiple sclerosis is defined by a chronic inflammatory process and the presence of large confluent plaques of demyelination. Ongoing disease activity is due to an active inflammatory process, mainly mediated by T lymphocytes and macrophages, and is associated with blood-brain-barrier damage. B lymphocytes and plasma cells are present especially in the lesions that occur during the late chronic stage of the disease. Although all plaques are characterized by demyelination, the patterns of oligodendroglia destruction and of damage to other tissue elements, such as axons and astrocytes, are variable in different cases. Oligodendrocytes are less affected by plaques that develop during the first bouts of the disease than by those plaques arising after several years of disease duration. Our data indicate that mechanisms of plaque formation may vary in different multiple sclerosis patients and in different stages of the disease process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions
Prineas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R., & Cho, E. ‐. (1993) · Annals of Neurology · doi:10.1002/ana.410330203 · Cited by 574
Oligodendrocytes in the early course of multiple sclerosis
Brück, W., Schmied, M., Suchanek, G., Brück, Y., Breitschopf, H., Poser, S., Piddlesden, S., & Lassmann, H. (1994) · Annals of Neurology · doi:10.1002/ana.410350111 · Cited by 216
Self-citation
Cited by
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
Brex, P. A., Ciccarelli, O., O'Riordan, J. I., Sailer, M., Thompson, A. J., & Miller, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011341 · Cited by 861
Blood-brain barrier disruption in multiple sclerosis
Minagar, A., & Alexander, J. S. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms965oa · Cited by 638
Miller, D. H. (2002) · Brain · doi:10.1093/brain/awf177 · Cited by 631
Monocyte/macrophage differentiation in early multiple sclerosis lesions
Brück, W., Porada, P., Poser, S., Rieckmann, P., Hanefeld, F., Kretzschmarch, H. A., & Lassmann, H. (1995) · Annals of Neurology · doi:10.1002/ana.410380514 · Cited by 530
Self-citationFilippi, M., Rocca, M. A., Martino, G., Horsfield, M. A., & Comi, G. (1998) · Annals of Neurology · doi:10.1002/ana.410430616 · Cited by 395
Davie, C. A., Barker, G. J., Webb, S., Tofts, P. S., Thompson, A. J., Harding, A. E., McDonald, W. I., & Miller, D. H. (1995) · Brain · doi:10.1093/brain/118.6.1583 · Cited by 377
Narayana, P. A., Doyle, T. J., Lai, D., & Wolinsky, J. S. (1998) · Annals of Neurology · doi:10.1002/ana.410430112 · Cited by 318
Neuropathology in multiple sclerosis: new concepts
Lassmann, H. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400301 · Cited by 306
Self-citationHigh field MRI correlates of myelin content and axonal density in multiple sclerosis
Mottershead, J. P., Schmierer, K., Clemence, M., Thornton, J. S., Scaravilli, F., Barker, G. J., Tofts, P. S., Newcombe, J., Cuzner, M. L., Ordidge, R. J., et al. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0192-3 · Cited by 296
Axonal Pathology in Multiple Sclerosis. A Historical Note
Kornek, B., & Lassmann, H. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00547.x · Cited by 197
Self-citationPrimary demyelination in transgenic mice expressing interferon-γ
Horwitz, M. S., Evans, C. F., Mcgavern, D. B., Rodriguez, M., & Oldstone, M. B. A. (1997) · Nature Medicine · doi:10.1038/nm0997-1037 · Cited by 179
van Horssen, J., Singh, S., van der Pol, S., Kipp, M., Lim, J. L., Peferoen, L., Gerritsen, W., Kooi, E.-J., Witte, M. E., Geurts, J. J., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-156 · Cited by 172
Long-term remyelination after optic neuritis
Brusa, A., Jones, S. J., & Plant, G. T. (2001) · Brain · doi:10.1093/brain/124.3.468 · Cited by 165
“Histopathological studies have shown that multiple sclerosis lesions can have a different pathogenesis in different patients and in different phases of the disease (Lassmann et al., 1994).”
BackgroundInfluentialMacrophages in Multiple Sclerosis
Brück, W., Sommermeier, N., Bergmann, M., Zettl, U., Goebel, H. H., Kretzschmar, H. A., & Lassmann, H. (1996) · Immunobiology · doi:10.1016/s0171-2985(96)80024-6 · Cited by 139
Self-citationAlbumin and multiple sclerosis
LeVine, S. M. (2016) · BMC Neurology · doi:10.1186/s12883-016-0564-9 · Cited by 105
Klistorner, A., Vootakuru, N., Wang, C., Yiannikas, C., Graham, S. L., Parratt, J., Garrick, R., Levin, N., Masters, L., Lagopoulos, J., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122114 · Cited by 59
“As only a small percentage of OR neurons die as a result of a single attack [25], it is likely that each “cylinder” is surrounded by preserved, but demyelinated axons within the lesion, and their myelinated continuation distal to the lesion (Fig.”
Background
Metadata
- Authors
- Lassmann, H., Suchanek, G., & Ozawa, K.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1994
- Volume
- 36
- Issue
- S1
- Pages
- S42-S46
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2080748802
- Cited by
- 124
- References
- 2
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.